PVCT.ob 1.01
100% retrace of the last move on slackening volume, no news in over forty days, several block trades yesterday
Provectus Pharmaceuticals, Inc., a development-stage biopharmaceutical company, engages in the development, licensing, and marketing of over-the-counter (OTC) products, prescription drugs, and medical device systems. The company’s OTC products include disposable gloves and Pure-ific line of products, including two quick-drying sprays, Pure-ific and Pure-ific Kids, which address problems, such as hand irritation associated with use of disposable gloves, eczema, and mild to moderate acne. Its prescription drugs provide invasive treatment of chronic severe skin afflictions, such as psoriasis, eczema, and acne; and various life-threatening cancers, such as those of the liver, breast, and prostate. The company is also developing medical devices for cosmetic treatments, such as reduction of wrinkles and elimination of spider veins and other cosmetic blemishes, as well as for therapeutic uses, including photoactivation of its prescription drugs and nonsurgical destruction of certain skin cancers.
 |
